Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells

References

• Meuillet E, Stratton S, Prasad Cherukuri D, Goulet AC, Kagey J, Porterfield B, Nelson MA. Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings. J Cell Biochem 2004;91(3): 443–458.
   PubMed Web of Science ®Google Scholar
• Lu J, Holmgren A. Selenoproteins. J Biol Chem 2009; 284(2):723–727.
   PubMed Web of Science ®Google Scholar
• Rayman MP. The use of high-selenium yeast to raise selenium status: how does it measure up? Br J Nutr 2004;92:557–573.
   PubMed Web of Science ®Google Scholar
• Letavayova L, Vlckova V, Brozmanova J. Selenium: from cancer prevention to DNA damage. Toxicology 2006;227:1–14.
   PubMed Web of Science ®Google Scholar
• Arthur JR, McKenzie RC, Beckett GJ. Selenium in the immune system. J Nutr 2003;133(5 Suppl 1):1457S–1459S.
   PubMed Web of Science ®Google Scholar
• Fischer JL, Lancia JK, Mathur A, Smith ML. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res 2006;26(2A):899–904.
   PubMed Web of Science ®Google Scholar
• Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346(Pt 1):1–8.
   PubMed Web of Science ®Google Scholar
• Lobanov AV, Hatfield DL, Gladyshev VN. Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta 2009;1790(11):1424–1428.
   PubMed Web of Science ®Google Scholar
• Hawkes WC, Alkan Z. Regulation of redox signaling by selenoproteins. Biol Trace Elem Res 2010;134(3):235–251.
   PubMed Web of Science ®Google Scholar
• Broadley MR, White PJ, Bryson RJ, Meacham MC, Bowen HC, Johnson SE, . Biofortification of UK food crops with selenium. Proc Nutr Soc 2006;65(2):169–181.
   PubMed Web of Science ®Google Scholar
• Zhao R, Domann FE, Zhong W. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Therapeut 2006;5:3275–3284.
   PubMed Web of Science ®Google Scholar
• Zhao R, Xiang N, Domann FE, Zhong W. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res 2006;66: 2296–2304.
   PubMed Web of Science ®Google Scholar
• Li GX, Lee HJ, Wang Z, Hu H, Liao JD, Watts JC, . Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 2008;29(5):1005–1012.
   PubMed Web of Science ®Google Scholar
• Gudkov AV. Converting p53 from a killer into a healer. Nat Med 2002;8(11):1196–1198.
   PubMed Web of Science ®Google Scholar
• Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007;9(7):775–806.
   PubMed Web of Science ®Google Scholar
• Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 1993;9(7):246–249.
   PubMed Web of Science ®Google Scholar
• Bravard A, Vacher M, Gouget B, Coutant A, de Boisferon FH, Marsin S, . Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol 2006; 26(20):7430–7436.
   PubMed Web of Science ®Google Scholar
• Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 2002;99(22):14548–14553.
   PubMed Web of Science ®Google Scholar
• Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, . Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int 2003;91(7):608–612.
   PubMed Web of Science ®Google Scholar
• Waters DJ, Shen S, Cooley DM, Bostwick DG, Qian J, Combs GF, Jr., . Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 2003;95(3):237–241.
   PubMedGoogle Scholar
• Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, . Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol 2009;27(22):3577–3583.
   PubMed Web of Science ®Google Scholar
• Erkekoglu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic Biol Med 2010;49(4):559–566.
   PubMed Web of Science ®Google Scholar
• Flohe L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984;105:114–121.
   PubMed Web of Science ®Google Scholar
• Arner ES, Zhong L, Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Meth Enzymol 1999;300:226–239.
   PubMed Web of Science ®Google Scholar
• Krieg RC, Dong Y, Schwamborn K, Knuechel R. Protein quantification and its tolerance for different interfering reagents using the BCA-method with regard to 2D SDS PAGE. J Biochem Biophys Meth 2005;65:13–19.
   PubMedGoogle Scholar
• Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN. DNA oxidation matters: the HPLC–electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA 1998; 95:288–293.
   PubMed Web of Science ®Google Scholar
• Mouret S, Philippe C, Gracia-Chantegrel J, Banyasz A, Karpati S, Markovitsi D, Douki T. UVA-induced cyclobutane pyrimidine dimers in DNA: a direct photochemical mechanism? Org Biomol Chem 2010;8(7):1706–1711.
   PubMed Web of Science ®Google Scholar
• Frelon S, Douki T, Ravanat JL, Pouget JP, Tornabene C, Cadet J. High-performance liquid chromatography—tandem mass spectrometry measurement of radiation-induced base damage to isolated and cellular DNA. Chem Res Toxicol 2000;13(10):1002–1010.
   PubMed Web of Science ®Google Scholar
• Baliga MS, Diwadkar-Navsariwala V, Koh T, Fayad R, Fantuzzi G, Diamond AM. Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol Nutr Food Res 2008;52(11):1300–1304.
   PubMed Web of Science ®Google Scholar
• Rebsch CM, Penna FJ, 3rd, Copeland PR. Selenoprotein expression is regulated at multiple levels in prostate cells. Cell Res 2006;16(12):940–948.
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Whiteside JR, McMillan TJ, Allinson SL. Cellular and sub-cellular responses to UVA in relation to carcinogenesis. Int J Radiat Biol 2009;85(3):177–195.
   PubMed Web of Science ®Google Scholar
• Bjelland S, Seeberg E. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat Res 2003; 531(1–2):37–80.
   PubMed Web of Science ®Google Scholar
• Shrivastav N, Li D, Essigmann JM. Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 2010;31(1):59–70.
   PubMed Web of Science ®Google Scholar
• Schuch AP, Menck CF. The genotoxic effects of DNA lesions induced by artificial UV-radiation and sunlight. J Photochem Photobiol B 2010;99(3):111–116.
   PubMed Web of Science ®Google Scholar
• Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003;63:3347–3351.
   PubMed Web of Science ®Google Scholar
• Zhuo P, Goldberg M, Herman L, Lee BS, Wang H, Brown RL, . Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res 2009; 69(20):8183–8190.
   PubMed Web of Science ®Google Scholar
• Suzuki KT, Ogra Y. Metabolic pathway for selenium in the body: speciation by HPLC-ICP MS with enriched Se. Food Addit Contam 2002;19(10):974–983.
   PubMedGoogle Scholar
• Fischer JL, Mihelc EM, Pollok KE, Smith ML. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther 2007;6(1): 355–361.
   PubMed Web of Science ®Google Scholar
• Seo YR, Sweeney C, Smith ML. Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene 2002;21(23):3663–3669.
   PubMed Web of Science ®Google Scholar
• Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000;461(2):83–108.
   PubMedGoogle Scholar
• Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 2003;170:2471–2474.
   PubMed Web of Science ®Google Scholar
• Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 2009;69(8):3642–3649.
   PubMed Web of Science ®Google Scholar
• Smith ML, Lancia JK, Mercer TI, Ip C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 2004;24(3a):1401–1408.
   PubMed Web of Science ®Google Scholar
• Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, Qian J, . Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 2005;26(7):1256–1262.
   PubMed Web of Science ®Google Scholar
• Lippman SM, Klein EA, PJ G, . Effect of selenium and vitamin E on risk of prosatate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2009;301(1):39–51.
   PubMed Web of Science ®Google Scholar
• Ledesma MC, Jung-Hynes B, Schmit TL, Kumar R, Mukhtar H, Ahmad N. Selenium and vitamin E for prostate cancer: post-SELECT status. Mol Med 2010.
   PubMed Web of Science ®Google Scholar
• Erkekoglu P, Rachidi W, Yuzugullu OG, Giray B, Favier A, Ozturk M, Hincal F. Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol Appl Pharmacol 2010;248(1):52–62.
   PubMed Web of Science ®Google Scholar